Covalent inhibitors meet epigenetics: New opportunities

Area of Science:

• Pharmacology
• Medicinal Chemistry
• Molecular Biology

Background:

• Epigenetic interventions are crucial for treating diseases like cancer.
• Current epigenetic drugs face challenges including low efficacy, toxicity, and drug resistance.
• Covalent inhibitors are emerging as a promising strategy to address these limitations.

Purpose of the Study:

• To review the design, mechanisms, and applications of covalent inhibitors targeting epigenetic regulators.
• To explore the potential of covalent epigenetic drugs in overcoming current therapeutic challenges.
• To identify new opportunities for developing advanced covalent epigenetic inhibitors.

Main Methods:

• Comprehensive literature search for covalent inhibitors targeting epigenetic regulators.
• Analysis of design strategies, reaction mechanisms, and covalent warheads.
• Evaluation of targeted amino acids and covalent verification methods.

Main Results:

• Over 40 covalent inhibitors targeting 29 distinct epigenetic targets were identified and analyzed.
• Detailed examination of covalent warheads, targeted amino acids, and reaction mechanisms.
• Discussion of the slow dissociation kinetics and improved target engagement of covalent inhibitors.

Conclusions:

• Covalent inhibitors represent a significant advancement in epigenetic drug development.
• These inhibitors show potential for enhanced efficacy, selectivity, and overcoming drug resistance.
• Further development of covalent epigenetic inhibitors is expected to yield significant therapeutic breakthroughs.